Polyestradiol Phosphate

CHEMBL1201477 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

Polyestradiol phosphate is a polymeric esterified form of estradiol that is slowly hydrolyzed after intramuscular injection to release free estradiol, providing long-lasting estrogenic activity as a depot preparation. It is used in the hormonal treatment of prostate cancer to suppress testosterone levels, and has also been investigated in breast cancer and leukemia treatment.

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Polyestradiol phosphate is a polymeric esterified form of estradiol that is slowly hydrolyzed after intramuscular injection to release free estradiol, providing long-lasting estrogenic activity as a depot preparation. It is used in the hormonal treatment of prostate cancer to suppress testosterone levels, and has also been investigated in breast cancer and leukemia treatment.

Yes, Polyestradiol Phosphate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201477. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.